The document discusses molecular diagnostics and genetic testing techniques. It provides an overview of molecular diagnostics, their significance in medicine, and how they are transforming fields like prenatal testing, disease detection, and drug selection. It then covers various immunological diagnostic methods like ELISA, radioimmunoassay, western blotting, and their characteristics. The document also discusses molecular genetic tests, genetic alterations detected, and techniques for DNA-based diagnosis of diseases. It focuses on the principles and procedures of molecular diagnostic methods like hybridization assays and PCR and their applications in detecting pathogens and genetic disorders.
Molecular diagnostics is a collection of techniques used to analyse biological markers in the genome and proteome—the individual's genetic code and how their cells express their genes as proteins—by applying molecular biology to medical testing.
Deciphering DNA sequences is essential for virtually all branches of biological research. With the
advent of capillary electrophoresis (CE)-based Sanger sequencing, scientists gained the ability to
elucidate genetic information from any given biological system. This technology has become widely
adopted in laboratories around the world, yet has always been hampered by inherent limitations in
throughput, scalability, speed, and resolution that often preclude scientists from obtaining the essential
information they need for their course of study. To overcome these barriers, an entirely new technology
was required—Next-Generation Sequencing (NGS), a fundamentally different approach to sequencing
that triggered numerous ground-breaking discoveries and ignited a revolution in genomic science.
It contains information about- DNA Sequencing; History and Era sequencing; Next Generation Sequencing- Introduction, Workflow, Illumina/Solexa sequencing, Roche/454 sequencing, Ion Torrent sequencing, ABI-SOLiD sequencing; Comparison between NGS & Sangers and NGS Platforms; Advantages and Applications of NGS; Future Applications of NGS.
Molecular diagnostics is a collection of techniques used to analyse biological markers in the genome and proteome—the individual's genetic code and how their cells express their genes as proteins—by applying molecular biology to medical testing.
Deciphering DNA sequences is essential for virtually all branches of biological research. With the
advent of capillary electrophoresis (CE)-based Sanger sequencing, scientists gained the ability to
elucidate genetic information from any given biological system. This technology has become widely
adopted in laboratories around the world, yet has always been hampered by inherent limitations in
throughput, scalability, speed, and resolution that often preclude scientists from obtaining the essential
information they need for their course of study. To overcome these barriers, an entirely new technology
was required—Next-Generation Sequencing (NGS), a fundamentally different approach to sequencing
that triggered numerous ground-breaking discoveries and ignited a revolution in genomic science.
It contains information about- DNA Sequencing; History and Era sequencing; Next Generation Sequencing- Introduction, Workflow, Illumina/Solexa sequencing, Roche/454 sequencing, Ion Torrent sequencing, ABI-SOLiD sequencing; Comparison between NGS & Sangers and NGS Platforms; Advantages and Applications of NGS; Future Applications of NGS.
This presentation covers a general introduction to expression vector, its components, types, and its application. Then it covers some of the expression system with examples.
This presentation covers a general introduction to expression vector, its components, types, and its application. Then it covers some of the expression system with examples.
MOLECULAR BIOLOGY TECHNIQUES USED IN ZOONOTIC DISEASE Nataraju S M
Zoonotic pathogens cause diseases and death both in human & animals which ultimately leads to man power and economic loss of the country. Traditional diagnostic methods identify a pathogen based on its phenotype.
The correct assessment of a clinical isolate takes more time. Faster and simpler methods of diagnosis is of great advantage. That is why molecular biology technique is the first and foremost choice .
Ebmt 2018 gps in mm koehne et al_with suppl slides_final_final_1.1.12_mar2018...Nicholas Sarlis
Galinpepimut-S (WT1-targeting peptide vaccine) in high-risk multiple myeloma. Final results from a Phase 2 clinical study. Koehne G, et al. EBMT 2018 slide presentation.
If a microbiologist is studying bacteria that premeditate, or break down, toxic wastes and wants to know which specific genes are active when that bacterium is degrading, say, PCBs, he would likely use a tool called the DNA microarray.
Microarrays enable scientists to monitor the activities of hundreds or thousands of genes at once. All microarrays (also called DNA chips or gene chips) work on the basic principle that complementary nucleotide sequences in DNA (and RNA) match up like the two halves of a piece of Velcro coming together.
Pattern of gene activity on a microarray chip.
A microarray consists of an orderly arrangement of bits of genetic material in super-tiny spots laid down in a grid on a suitable surface, often a glass slide with a specially chemically treated surface.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
1. CHC 812: CELL BIOLOGY, GENETICS,
IMMUNOLOGY AND TERATOLOGY
Lecture 01, 2015
Molecular Diagnostics
Lecturer: Dr. G. Kattam Maiyoh
GKM/M.MEDPAEDS/LECT 01/2015
2. Molecular Diagnostics
The use of molecular biology techniques to
expand scientific knowledge of the natural
history of diseases, identify people who are at
risk for acquiring specific diseases, and
diagnose human diseases at the molecular
level.
GKM/M.MEDPAEDS/LECT 01/2015
3. Molecular Diagnostic
• USE OF:
– Sequence Specific INFORMATION
• in
– MACROMOLECULES
• for
– Risk identification
– Diagnosis
– Prognosis
– Prediction of response to therapy
– Monitoring therapeutic responses
GKM/M.MEDPAEDS/LECT 01/2015
5. Molecular Diagnostics: Significance
To face the near future, the medical practitioner not only
understand molecular biology, but must also embrace
the use of this rapidly expanding body of information in
his medical practice, whether practicing family medicine
pediatrics, oncology, obstetrics and gynecology,
pathology, or any other medical specialty.
GKM/M.MEDPAEDS/LECT 01/2015
6. Molecular Diagnostics are Transforming Medicine
Pre-natal testing
Disease predisposition
Disease detection
Drug selection
Recurrence monitoring
Key questions
-> Need for Molecular tests
“Is the baby
healthy? “
“What diseases
is this patient at
risk for?”
“Does this
patient have a
disease?”
“What drugs
should I
prescribe?”
“Has the disease
returned?”
Molecular
diagnostics is
>$3 billion
market WW and
growing at >20%
annually
GKM/M.MEDPAEDS/LECT 01/2015
7. Old vs. New Molecular Diagnostics
• Old: grow cells/pathogen->test
• Such growth can be a problem as it is
sometimes slow AND costly.
• New: direct test (either immunological or
DNA/RNA based)
GKM/M.MEDPAEDS/LECT 01/2015
8. Characteristics of a Detection System
• A good detection system should have 3 qualities:
♣ Sensitivity
♣ Specificity
♣ Simplicity
• Sensitivity means that the test must be able to detect very
small amounts of target even in the presence of other
molecules.
• Specificity: the test yields a positive result for the target
molecule only.
• Simplicity: the test must be able to run efficiently and
inexpensively on a routine basis.
Molecular Diagnostics
GKM/M.MEDPAEDS/LECT 01/2015
10. Target antigens and polyclonal versus
monoclonal antibodies
Polyclonal antibodies are made against and react with
multiple antigenic sites (epitopes) on a target antigen.
Monoclonal antibodies are directed against a particular
antigenic site.
Target antigen
with various antigenic
determinants (epitopes)1
2 3 4
5
67
GKM/M.MEDPAEDS/LECT 01/2015
14. Enzyme-Linked Immunosorbent Assay (ELISA):
Immunological detection
Target molecule
antigenic site
iiiiiiiiiiiiiii
Support
A. Bind sample to the support (commonly plastic or a membrane)
B. Add primary antibody; wash
C. Add secondary antibody-enzyme conjugate; wash
D. Add substrate
Y
YY
Y
bound primary
antibody
YE
YE
YEYE
enzyme linked
secondary antibody
colorless substrate
colored product
GKM/M.MEDPAEDS/LECT 01/2015
15. Immunological Diagnostics Methods - ELISA
• Addition of a specific antibody (primary
antibody) which will bind to the test
molecule if it is present.
• Washing to remove unbound molecules.
• Addition of secondary antibody which will
bind to the primary antibody.
• The secondary antibody usually has attached
to it an enzyme e.g. alkaline phosphatase.
• Wash to remove unbound antibody.
• Addition of a colourless substrate which will
react with the secondary antibody to give a
colour reaction which indicates a positive
result.
-> can be used for quasi High-throughput!!!
GKM/M.MEDPAEDS/LECT 01/2015
16. ELISA -Variants
Detection based on
enzyme catalyzed
reactions:
1.alkaline Phosphatase
2.horseradish peroxidase
3. β-galactosidase
Detection based on
fluorescent labeled
secondary antibody
GKM/M.MEDPAEDS/LECT 01/2015
17. ELISA –Variants
The ELISPOT
The ELISPOT assay -> to determine
quantitatively the # of cells in a population
that are producing specific Ab or cytokine.
-> precipitates & forms a spot only on the
areas of the well where cytokine-secreting
cells had been deposited.
P.T.O
GKM/M.MEDPAEDS/LECT 01/2015
19. Western blot
SDS-Page: separates the components
according to their molecular weight.
Blot: the proteins in the gel are
transferred to the sheet of
nitrocellulose or nylon by the passage
of an electric current.
Immunoreaction: probed with Ab & then
radiolabeled or enzyme-linked 2nd
Ab.
Detection: a position is visualized by
means of an ELISA reaction.
GKM/M.MEDPAEDS/LECT 01/2015
23. Immunofluorescence
Fluorochromes
-Fluorescein (490 517nm)→
-Rhodamine (515 546nm)→
-Phycoerythrin
mIgM-producing B cells indirectly stained with rhodamine-conjurated
secondary Ab under a fluorescence microscope.
Protein A has the ability to bind to IgG
GKM/M.MEDPAEDS/LECT 01/2015
24. Immuno Electron Microscopy
electron-dense labels
absorb electrons.
An immunoelectronmicrograph
of the surface of a B-cell
lymphoma was stained with two
antibodies (Ab against class II
MHC labeled with 30nm gold
particles, & another Ab against
class I MHC w/ 15nm gold
particles.
(The density of class I exceeds
that of class II)
- Electron-dense label (ferritin
or colloidal gold) is conjugated
to the Fc
portion.
GKM/M.MEDPAEDS/LECT 01/2015
25. We now know how God
wrote the book of life
Bill Clinton
30. Preimplantation Diagnosis/
Screening
• Prenatal diagnosis or
prenatal screening (note
that prenatal diagnosis
and prenatal screening
refer to two different
types of tests) is testing
for diseases or
conditions in a fetus or
embryo before it is born.
GKM/M.MEDPAEDS/LECT 01/2015
32. DNA diagnostic systems
1. Bind ssDNA (target) to membrane
2. Hybridize to labeled ssDNA or RNA (probe)
3. Wash membrane to remove unbound probe
4. Detect hybrid sequences formed between the
probe and target DNA (concern: false +s & -s)
membrane
GKM/M.MEDPAEDS/LECT 01/2015
34. Ordering Molecular genetic Tests
• Specimen Handling
• DNA-based tests:
– Room temperature, up to 72 hours (maybe
more with special buffers)
• RNA-based tests:
– Deliver ASAP (4-6 hours)
– Special considerations for proprietary test.
GKM/M.MEDPAEDS/LECT 01/2015
35. Ordering Molecular genetic Tests
• Essential info:
– Clinical information
– pedigree, if possible
– Race
– reason for testing.
• Informed consent:
• Nature of test; availability of genetic counseling;
implications of positive and negative tests, etc.
GKM/M.MEDPAEDS/LECT 01/2015
37. DNA based diagnosis of Malaria and
Typanosoma cruzi
1. A DNA probe from a highly repeated DNA sequence
of Plasmodium falciparum, the parasite that causes
malaria, is used to screen blood samples via
hybridization assays
2. DNA primers are made against the ends of a 188 bp
repeated sequence contained in the protozoan
parasite Typanosoma cruzi, the causative agent of
Chagas disease and used in a PCR/polyacrylamide
gel electrophoresis detection method
• Other examples of DNA-based detection:
Salmonella typhi (food poisoning), certain E. coli
(gastroenteritis), Mycobacterium tuberculosis
(tuberculosis), etc.GKM/M.MEDPAEDS/LECT 01/2015
38. Nonradioactive Hybridization Procedures
• Use of biotin-labeled nucleotides in DNA probes
instead of 32
P, then add avidin (streptavidin) which
binds to biotin, and then add biotin attached to an
enzyme like alkaline phosphatase for detection (see
Fig. 9.11)
• Note that fluorescent dyes can also be attached to
DNA primers for detecting amplified DNA products
(see Fig. 9.12)
GKM/M.MEDPAEDS/LECT 01/2015
41. DNA Fingerprinting & Forensics
• History
• Uses of DNA Profiling
• Hypervariable DNA sequences examined (RFLPs, VNTRs,
STRs, SNPs, mitochondrial DNA, Y chromosomal DNA)
• Methods (Southerns & PCR)
• Statistical considerations
• Technical considerations
• Databases and Privacy
GKM/M.MEDPAEDS/LECT 01/2015
42. DNA Fingerprinting
• You're 99.9% identical
• But of course, you are unique--in a genome of three
billion letters, even a 0.1 % difference translates into
three million differences.
• These differences (or polymorphisms) reside in
several places in the genome, often in microsatellites
• Examples of such polymorphisms include VNTRs,
STRs, RFLPs and SNPs
– Variable number tandem repeats
– Short Tandem Repeats
– Restriction fragment length polymorphism
– Single Nucleotide Polymorphism
GKM/M.MEDPAEDS/LECT 01/2015
43. DNA Fingerprinting
• Focuses on the 0.1-1.0% of human DNA that is
unique
• First described in 1985 by Dr. Alec Jeffreys in
England
• DNA evidence is admissible in courts
GKM/M.MEDPAEDS/LECT 01/2015
44. Uses of DNA fingerprinting
• Paternity testing
• Identification of criminals (e.g. murderers, rapists,
letter bombers)
• Immigration disputes (family relationships)
• Identification of deceased individuals with mutilated
or decomposed bodies (e.g., the military, bomb blast)
• Identifying the sperm donor who “decorated” Monica
Lewinsky’s blue dress
GKM/M.MEDPAEDS/LECT 01/2015
45. Preparation of a DNA fingerprint
Step 1
• Specimen collection
– blood, semen, etc
– Easy to contaminate a DNA sample with DNA from
other sources (bacteria, DNA of person collecting
sample)
– DNA is not stable for very long-it degrades
• sunlight
• heat
• moisture
January 23, 2015 47
GKM/Forensic and Clinical Bioc./Lec
03/2013
46. • DNA fingerprinting is a comparative process:
– DNA from crime scene is compared with DNA of a
suspect
– So minimum of two samples must be prepared
Step 2
• DNA extraction
– standardized methods have been developed
– need to separate DNA from other cell material
and debris from crime scene.
January 23, 2015 48
GKM/Forensic and Clinical Bioc./Lec
03/2013
47. Step 3
• PCR using primers targeting STRs at different loci
• PCR amplify STRs using target sites on
chromosome
January 23, 2015 49
GKM/Forensic and Clinical Bioc./Lec
03/2013
48. Step 3
PCR amplification of DNA
1 strand
of DNA
Heat to
denature
double-
stranded
DNA
Design primers that anneal to STR locus
Amplify all the regions of the chromosome
where the STRs exist.
STR locus
STR locus
January 23, 2015 50
GKM/Forensic and Clinical Bioc./Lec
03/2013
49. PCR allows you to
make millions of
copies of the STR
region from a single
copy of DNA you
recovered from crime
scene.
January 23, 2015 51
GKM/Forensic and Clinical Bioc./Lec
03/2013
50. • Since the # of times sequence is repeated is
different for each person, fragment size will be
different.
• This is done for 13 different STR sequences
• Differences occur among individuals at each of
the 13 loci on the chromosome where the STRs
occur
• This allows for a lot of variation
January 23, 2015 52
GKM/Forensic and Clinical Bioc./Lec
03/2013
51. Restriction Fragment Length Polymorphism
G-G-C-C-X-X-X-G-G-C-C-X-X.. G-G-G-C-C-X-X-G-G-C-C-X-X…..
STR
C-C-X-X-X-G-G
C-C-X-X-G-G
PCR amplify
STR region
STR
well well
Gel
electrophoresis
Person A Forensic sample
For 1 STR sequence at 1 locus
January 23, 2015 53
GKM/Forensic and Clinical Bioc./Lec
03/2013
52. • If you do this for 13 different repeat sequences at 13
different loci on the chromosome, each person
produces a different band pattern when the
fragments are separated by gel electrophoresis
• Banding patterns are identified using specific probes
(see next slide)
• Since the patterns are unique to an individual, they
are referred to as DNA finger prints
January 23, 2015 54
GKM/Forensic and Clinical Bioc./Lec
03/2013
Banding Patterns
53. Some examples of DNA fingerprinting
• Paternity cases
• Crime scenes
GKM/M.MEDPAEDS/LECT 01/2015
57. Technical Considerations
• Preserve the integrity of DNA sample
• Avoid DNA contamination & degradation
• Avoid incomplete digestions if REs are used
• Use standard hybridization conditions
• Use standard PCR primers and procedures
• Gel analysis is less reproducible than capillary
electrophoresis of PCR products
GKM/M.MEDPAEDS/LECT 01/2015
58. Test Choice
• Cost
• Sample requirements
• Turnaround time
• Sensitivity/Specificity
• Positive/ Negative predictive value
• Type of mutation detected
• Genotyping vs mutation scanning
GKM/M.MEDPAEDS/LECT 01/2015
59. DNA databases
• Already in place in the FBI for convicted felons (i.e.,
CODIS-COmbined DNA Index System, involves 13 STR
loci) and the Dept. of Defense for armed service
personnel and the Virginia saliva and blood bank of
convicted felons
• A national DNA database has been suggested. What
do you think?
• Could current or potential employers or insurance
companies base decisions they make on this kind of
data?
GKM/M.MEDPAEDS/LECT 01/2015
60. • A way to quantitate
DNA in a PCR
• Involves the use of
SYBR green dye
• SYBR green only
binds to and
fluoresces with
dsDNA (detect
product)
GKM/M.MEDPAEDS/LECT 01/2015
61. Bacterial biosensors
• One example involves using Pseudomonas
fluorescens (genetically engineered for
bioluminescence) to monitor pollutants
• If pollutants are present in a sample, then cell
death occurs and “the light goes out”
lux genes in the
chromosomal DNA
GKM/M.MEDPAEDS/LECT 01/2015
62. Bacterial biosensors (another example)
• Green fluorescent protein (GFP) can be used a
reporter gene under the control of some inducible
promoter (e.g., one that responds to some
environmental signal such as a toxin)
• If the signal is present GFP will be produced
GKM/M.MEDPAEDS/LECT 01/2015